- Previous Close
15.05 - Open
15.05 - Bid 14.65 x --
- Ask 14.80 x --
- Day's Range
14.65 - 15.05 - 52 Week Range
13.90 - 46.30 - Volume
114,701 - Avg. Volume
187,035 - Market Cap (intraday)
1.416B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-1.19 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Meribank Biotech Co., Ltd researches, develops, manufactures, and stores mesenchymal stem cells in Taiwan. The company engages in the storage of placental umbilical cord mesenchymal stem cells, cord blood hematopoietic stem cells, and immune cells. It also provides cell cryopreservation services. Meribank Biotech Co., Ltd was founded in 2013 and is based in Taipei City, Taiwan.
www.meribank.com.twRecent News: 4724.TWO
View MorePerformance Overview: 4724.TWO
Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4724.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4724.TWO
View MoreValuation Measures
Market Cap
1.44B
Enterprise Value
2.22B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.93
Price/Book (mrq)
1.19
Enterprise Value/Revenue
6.05
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-25.85%
Return on Assets (ttm)
-2.93%
Return on Equity (ttm)
-10.27%
Revenue (ttm)
366.43M
Net Income Avi to Common (ttm)
-94.71M
Diluted EPS (ttm)
-1.19
Balance Sheet and Cash Flow
Total Cash (mrq)
165.09M
Total Debt/Equity (mrq)
77.45%
Levered Free Cash Flow (ttm)
-330.4M